GSK-206899

Study Sponsor: GSK

Study Title

A Phase IIa Single-Center, Open-Label Study Evaluating the Pharmacokinetics of Repeat Oral Doses of Gepotidacin (GSK2140944) in Adult Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Medicine or Vaccine (generic name)

gepotidacin

Sponsor Identification Number

206899

Trial Registry Identification Number(#'s)

NCT03568942

Medical Condition

Infections, Bacterial

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=206899

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03568942

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The data for this study is available in CDISC format.

Date Added to this Site

May 2020